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Abstract 
Thiophene derivatives have shown versatile pharmacological activities. The Suzuki reaction proved a convenient 
method for C–C bond formations in organic molecules. In the present research work novel derivatives of 2,5‑dibromo‑
3‑methylthiophene (3a–k and 3l–p) has been synthesized, via Suzuki coupling reaction in low to moderate yields. 
A wide range of functional groups were well tolerated in reaction. Density functional theory investigations on all 
synthesized derivatives (3a–3p) were performed in order to explore the structural properties. The pharmaceutical 
potential of synthesized compounds was investigated through various bioassays (antioxidant, antibacterial, antiu‑
rease activities). The compounds 3l, 3g, 3j, showed excellent antioxidant activity (86.0, 82.0, 81.3%), respectively by 
scavenging DPPH. Synthesized compounds showed promising antibacterial activity against tested strains. 3b, 3k, 
3a, 3d and 3j showed potential antiurease activity with 67.7, 64.2, 58.8, 54.7 and 52.1% inhibition at 50 µg/ml. Results 
indicated that synthesized molecules could be a potential source of pharmaceutical agents.
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Background
Thiophene is found in central core of various compounds 
and is well known for its intrinsic electronic properties 
[1, 2]. A number of thiophene based heterocycles have 
been reported for versatile pharmacological activities [3–
9]. Biaryl thiophenes are pharmacologically important 
agents and widely used as anti-inflammatory [10], chem-
otherapeutic [11], antimicrobial [12] and antioxidant 
agents [13]. Several reports about regioselective Suzuki 
coupling of dibromothiophene are available in litera-
ture [14, 15]. Palladium catalyzed coupling of 2,5-dibro-
mothiophene has been reported and the yield of obtained 
product was low (29%) [16]. Synthesis of 2,5-diheteroar-
ylated thiophenes from 2,5-dibromo thiophene deriva-
tives has been reported in good yield [17]. Regioselective 
Suzuki coupling of 2,5-dibromo-3-hexylthiophene has 
been reported and preferably coupling occurred at C5 
position [18]. The more electron deficient carbon moi-
ety is preferably reactive towards attacking nucleo-
philes, whereas other reactive carbons do not show any 
response. Different heterocycles undergo electrophilic 
substitutions and this regioselectivity can be applied 
to these substrates [19]. In heterocycles substitution 
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reactions, heteroatom (O, S and N) electron lone pair 
is being donated to the ring. However, in halogenated 
thiophenes Suzuki reaction with high oxidative addition, 
the arylboronate anion preferably attacks the electron 
deficient carbon bonded with the halogen. And it was 
observed that transmetallation step is faster due to nega-
tively charged boronate anion then the neutral boronic 
acids [20]. Extending the scope of Suzuki coupling reac-
tion in regioselective domain a series of 2,5-dibromo-
3-methylthiophene derivatives has been synthesized 
specially with aim to explore their biological importance 
for the first time.
Results and discussion
Chemistry
A series of thiophene derivatives (3a–k) and (3l–p) has 
been synthesized by reaction of 2,5-dibromo-3-methylth-
iophene with variety of arylboronic acids in low to mod-
erate yields (27–63%) (Scheme 1, Table 1). 
Under the developed Suzuki reaction conditions, when 
1.1 eq of arylboronic acid was used the bromo group at 
5 position was selectively substituted and a variety of 
mono-substituted products was synthesized (3a–k) and 
double Suzuki cross coupling occurred by using 2.2 eq 
of arylboronic acids and diaryl derivatives of thiophene 
were synthesized (3l–p) (Table  1). To increase the sub-
strate scope, the arylboronic acids with both electron 
donating and withdrawing groups were used. The reac-
tion conditions were tolerant of both electron donating 
and electron withdrawing arylboronic acids. It was noted 
that some products were obtained in low yield as 3b, 3h, 
3i, 3j, 3k, 3n, 3o which can be attributed to the presence 
of mixture of mono and di-arylated products in both 
single and double Suzuki cross coupling reaction and it 
has been very difficult to separate this reaction mixture 
and low yields were obtained. This may be due to ineffec-
tive transmetallation and reductive elimination in overall 
reaction cycle [12].
Density functional theory (DFT) studies
DFT investigations were computed by using GAUSSIAN 
09 software, in order to explore the structural proper-
ties and reactivity’s of synthesized derivatives. First of all, 
compounds (3a–3p) were optimized by using B3LYP/6-
31G(d,p) basis set along with the frequency analysis. 
After optimization the energy minimized structures were 
used further for frontier molecular orbitals and molecu-
lar electrostatic potential (MEP) analysis on the same 
basis set.
Frontier molecular orbitals (FMOs) analysis
Nowadays frontier molecular orbitals analysis is well 
known to explain the reactivity of compounds [21] by 
using different computational methods. The HOMO/
LUMO band gap has direct correlation with the reactiv-
ity, e.g. if the band is less the compound will be kineti-
cally less stable (more reactive) and vice versa [22]. The 
FMOs analysis of all derivatives (3a–3p) was carried out 
by using B3LYP/6-31G(d,p) basis set. As observed from 
the HOMO/LUMO, the trend of dispersion of isoden-
sity was almost similar in all compounds. Therefore, as 
a model here we have given the HOMO/LUMO surfaces 
of compound 3a only (Fig.  1) (the rest are provided in 
Additional file 1: Figure S1). The corresponding HOMO 
and LUMO energies along with band gap are narrated in 
Table 2.
Scheme 1 Synthesis of 2‑bromo‑3‑methyl‑5‑arylthiophenes (3a–k) and 2,5‑diaryl‑3‑methyl thiophenes (3l–p). Conditions: (i) 1 (128 mg, 0.5 mmol, 
1 eq), 2 (0.55 mmol, 1.1 eq), Pd(PPh3)4 (14.5 mg, 2.5 mol%),  K3PO4 (212 mg, 1.0 mmol, 2 eq), 1,4‑dioxane (2.5 ml),  H2O (0.625 ml), 12 h, 90 °C under 
argon. (ii) 1 (128 mg, 0.5 mmol, 1 eq), 2 (1.25 mmol, 2.5 eq,), Pd(PPh3)4 (34.6 mg, 6 mol%),  K3PO4 (424 mg, 2.0 mmol, 4 eq), 1,4‑dioxane (2.5 ml),  H2O 
(0.625 ml), 12 h, 90 °C under argon
Page 3 of 12Rizwan et al. Chemistry Central Journal  (2018) 12:49 
The isodensity in HOMO of all compounds is dispersed 
on the benzene and thiophene moieties along with 
the groups attached to the main skeleton. It is clearly 
reflected from Fig. 1, that in HOMO orbitals the methyl 
group attached to the thiophene ring and the groups 
attached to the para position are directly involved in elec-
tronic cloud and electronic transition. Whereas isoden-
sity in LUMO of all compounds reflected the similar 
Table 1 Substrate scope of Suzuki cross coupling reaction of 2,5-dibromo-3-methyl thiophene with variety of arylbo-
ronic acids
3a (HOMO) 3a (LUMO)
Fig. 1 HOMO/LUMO surfaces of compounds (3a)
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trend, the methyl attached to thiophene ring and groups 
attached to the ortho position of benzene did not partici-
pate in electronic cloud. The HOMO–LUMO band gap 
in all compounds found in the range 3.89–4.67  eV. The 
smallest band gap observed for 3n i.e. 3.89 eV and largest 
band gap observed for 3p i.e. 4.67  eV. HOMO–LUMO 
band gap is reflecting that 3n is most reactive and less 
stable among all, whereas 3p is most stable and less reac-
tive. This is might be that 3n has more planer structure, 
due to which transition of electrons is more feasible, 
whereas in 3p the structure is non-planer and does not 
facilitating the promotion of electrons to higher orbitals 
easily.
Molecular electrostatic potential (MEP)
Molecular electrostatic potential study by using quan-
tum chemical tools is useful to explain reactivity, charge 
separations and monovalent interactions of molecules 
[23]. ESP analysis of compounds 3a–3p was computed by 
using DFT/B3LYP/6-31G(d,p) basis and graphics (Fig. 2). 
The range of MEP values of all compounds are given in 
Additional file 1: Table S1.
In ESP analysis, the dispersion of electronic density is 
explained on the basis of different colors e.g. the red color 
indicates the –ve potential and blue color is indicative of 
+ve potential [24]. It is cleared from ESP analysis that the 
electronic density in every compound is dispersed with 
respect to the electronic effect of group attached to the 
benzene moiety. The groups attached to the para posi-
tion of benzene ring have direct effect on the electronic 
cloud of whole molecule. In 3a, the electron withdraw-
ing group (fluoro) is attached to the benzene ring, due to 
which the –ve potential is dispersed bromo, chloro and 
fluoro groups instead of concentrating on benzene ring. 
Whereas in 3b the –ve potential is concentrated on ben-
zene and thiophene ring due to electron donating effect 
of –OCH3 attached to the para position on benzene ring. 
Almost similar kind of effect is observed in ESP analysis 
of all other synthesized derivatives. If electron donating 
group is attached to the ortho or para position of benzene 
moiety the electronic density is concentrated on the ben-
zene and thiophene rings (rather the electronic density 
also depends on the electron donating ability of group as 
well), such as in compounds 3c, 3f, 3g, 3h, 3i, 3k, 3m, 3n, 
3o and 3p. In all these molecules the –ve potential is con-
centrated on the benzene and thiophen rings, whereas in 
the rest of molecules the –ve potential is concentrated on 
the different groups attached at the different positions of 
scaffolds (Fig. 2).
Antioxidant activity by DPPH radical scavenging assay
Antioxidants have been broadly studied for their capabil-
ity to protect cells and organisms from the harm induced 
by reactive oxidative species (ROS) [25, 26]. So, scien-
tists are more interested to find sources for antioxidants 
which may be either natural or synthetic.
The DPPH radical has been widely used for determin-
ing antioxidant activity of various systems [27]. DPPH 
radical is purple in colour and antioxidants decay that 
purple colour of DPPH by capturing free radicals. The 
potential of DPPH scavenging can be quantified by not-
ing absorbance at 517 nm. A study was designed to deter-
mine the antioxidant potential of some novel thiophene 
derivatives (3a–k and 3l–p), by DPPH radical scavenging 
assay (Table 3). Ascorbic acid was used as control which 
exhibited 100% DPPH scavenging at 50 µg/ml. The com-
pounds 3l, 3g, 3j, showed excellent antioxidant activity 
(86.0, 82.0, and 81.3%), respectively by scavenging DPPH. 
It is noted that some compounds (3d, 3n) showed mild 
antioxidant activity with 48.2, 40.9% DPPH radical scav-
enging at 50 µg/ml. However other compounds showed 
significant antioxidant activity by scavenging DPPH while 
some compounds exhibited low activity (Table 3). Mab-
khot and coworkers found some thiophene moiety con-
taining compounds inactive towards scavenging DPPH 
and proved them poor antioxidants [28]. The substituents 
on ring system have pronounced effect on DPPH radical 
scavenging [29]. So, in light of this reference, this may be 
cause of variability in DPPH radical scavenging of thio-
phene based compounds.
Antibacterial activity
Thiophene and its various derivatives have been reported 
for potential anti-microbial activity [30–32]. To over-
come the drug resistance issues it is very important to 
Table 2 HOMO and LUMO energies, along with band gap
Compounds no EHOMO (eV) ELUMO (eV) ΔE (eV)
3a − 5.93 − 1.39 4.54
3b − 5.39 − 0.92 4.47
3c − 5.83 − 1.38 4.45
3d − 5.99 − 1.50 4.49
3e − 5.84 − 1.69 4.15
3f − 5.39 − 1.12 4.26
3g − 6.08 − 1.77 4.31
3h − 5.60 − 1.06 4.52
3i − 5.60 − 1.05 4.55
3j − 6.04 − 1.43 4.61
3k − 5.91 − 1.40 4.50
3l − 5.81 − 1.59 4.21
3m − 4.98 − 0.86 4.12
3n − 5.06 − 1.16 3.89
3o − 5.24 − 1.04 4.19
3p 6.05 − 1.38 4.67
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Fig. 2 ESP maps of compounds 3a–3p, calculated at DFT/B3LYP/6‑31G(d,p) level
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develop new anti-microbial agents. Generally in the field 
of pharmaceutical, new drugs are developed by molecu-
lar modification of well-known compounds whose activ-
ity is already established. So a novel series of thiophene 
derivatives (3a–k and 3l–p) were screened for anti-
bacterial activity against variety of Gram-positive and 
Gram-negative bacterial strains. Percentage inhibition of 
bacterial growth was examined at concentration (50 μg/
ml). For examining the antibacterial activity of series 
3a–k and 3l–p, streptomycin was used as standard drug 
which showed 100% inhibition against various bacterial 
strains (Table  4). Compounds 3a, 3k, 3i showed high-
est activity against P. aeruginosa with % inhibition 67.3, 
50.5, 41.1% at 50 μg/ml while compounds 3b, 3h, 3d and 
3n showed moderate activity with 39.2, 37.6, 34.9, 20.8% 
inhibition. This series of thiophene compounds did not 
show any activity against B. subtilis. When activity was 
observed against E. coli compounds 3a, 3k, 3i showed 
excellent activity with 94.5, 72.5, 70.4% inhibition. While 
3b, 3h and 3n showed moderate inhibitory effect against 
E. coli. Compound 3a and 3k showed moderate activity 
against S. aureus and S. typhimurium while compound 
3b and 3i showed low activity against these two strains. 
It was observed that compounds 3c, 3e, 3f, 3g, 3j, 3l, 3m, 
3o and 3p were found inactive against P. aeruginosa, B. 
subtilis, E. coli, S. aureus and S. typhi (Table 4).
The compounds with both electron donating and with-
drawing groups showed good to moderate antibacte-
rial activity. This activity was found promising for future 
benefits of these compounds as anti-bacterial agents. All 
the thiophene derivatives that were tested for antibacte-
rial activity were found inactive against B. subtilis. Previ-
ous reports about substituents effects on anti-microbial 
Table 3 Antioxidant potential of compounds (3a–k and 3l–
p) by DPPH radical scavenging activity
*** Showed no activity. The results are average ± SD of triplicate experiments 
p < 0.05
Entry Compounds no Percentage inhibition at 50 µg/ml
1 3a 33.4 ± 0.29
2 3b 23.9 ± 0.31
3 3c 37.5 ± 0.42
4 3d 48.2 ± 0.42
5 3e 38.5 ± 0.42
6 3f 39.2 ± 0.42
7 3g 82.0 ± 0.78
8 3h ***
9 3i 28.9 ± 0.45
10 3j 81.3 ± 0.72
11 3k 21.9 ± 0.32
12 3l 86.0 ± 0.73
13 3m 1.19 ± 0.02
14 3n 40.9 ± 0.21
15 3o 15.1 ± 0.21
16 3p 30.9 ± 0.29
17 Ascorbic acid 100 ± 0.99
Table 4 Antibacterial activity of synthesized compounds (3a–k and 3l–p) against Gram positive and Gram negative bac-
teria
*** Showed no activity. The results are average ± SD of triplicate experiments p < 0.05. Streptomycin was used as control standard drug
Entry Product no % inhibition (50 μg/ml)
P. aeruginosa B. subtilis E. coli S. aureus S. typhi
1 3a 67.3 ± 0.76 *** 94.5 ± 0.09 33.9 ± 0.37 27.6 ± 0.08
2 3b 39.2 ± 0.45 *** 50.1 ± 0.29 9.57 ± 0.15 5.58 ± 0.05
3 3c *** *** *** *** ***
4 3d 34.9 ± 0.27 *** 7.8 ± 0.09 *** 8.34 ± 0.23
5 3e *** *** *** *** **
6 3f *** *** *** *** ***
7 3g *** *** *** *** ***
8 3h 37.6 ± 0.26 *** 50.4 ± 0.45 *** 12.0 ± 0.02
9 3i 41.1 ± 0.47 *** 70.4 ± 0.78 *** 2.59 ± 0.01
10 3j *** *** *** *** ***
11 3k 50.5 ± 0.58 *** 72.5 ± 0.87 20.1 ± 0.06 17.3 ± 0.05
12 3 l *** *** *** *** ***
13 3m *** *** *** *** ***
14 3n 20.8 ± 0.17 *** 30.6 ± 0.26 *** *
15 3o *** *** *** *** ***
16 3p *** *** *** *** ***
17 Control 100 ± 1.28 100 ± 1.21 100 ± 1.01 100 ± 0.99 100 ± 0.99
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activity of thiophene based compounds are available 
in literature [31–33]. This context is a great deal for 
researchers to determine the medicinal values of thio-
phene based compounds.
Antiurease activity
The metalloenzyme urease involved in catalyzing the 
hydrolysis of urea. It is present in some plant varieties, 
algae, microbes and as well in soil enzymes [34]. This 
enzyme is involved in pathogenesis of various diseases 
and cause significant environmental and agriculture 
issues [35]. Several compounds have been reported as 
urease inhibitors to reduce agriculture, environmental, 
medical issues and to enhance the uptake of urea [36]. 
Heteroaryl pharmacophores have potential inhibitory 
activity against bacterial and plant urease [37]. A library 
novel of thiophene based compounds (3a–k, 3l–p) were 
screened for antiurease activity (Table 5), where thiourea 
was used as positive control and it showed 98.3% urease 
inhibition at 50  µg/ml. From these series of thiophene 
compounds 3b, 3k, 3a, 3d and 3j showed potential antiu-
rease activity with 67.7, 64.2, 58.8, 54.7 and 52.1% inhi-
bition at 50  µg/ml. It was noted that some compounds 
3c, 3e, 3f, 3g, 3h and 3i showed moderate antiurease 
activity. Some of the novel synthesized products exhib-
ited relatively higher antiurease activity while other 
products showed moderate urease inhibition effects. 
It is concluded that compounds with electron donat-
ing substituents on aryl ring have pronounced effect on 
urease inhibition and those compounds showed higher 
antiurease activity. While compounds with electron 
withdrawing substituents showed less activity. This may 
be due to decrease in metal chelating activity caused by 
electron withdrawing substituents and vice versa. These 
results are in agreement with previously reported antiu-
rease activity of thiophene based compounds [33–38]. 
According to previous study chelation/removal of nickle 
ions resulted in inactivation of the enzyme [39]. There-
fore change in electronic environment and position and 
orientation of functional groups can be attributed to vari-
ability in antiurease activity of different compounds.
Methods
General
The starting materials were purchased from Fisher Scien-
tific company (Pittsburgh, PA, USA) and Sigma Aldrich 
Chemical Company (St. Louis MO, USA). Characteriza-
tion of compounds was done by 1H, 13C NMR Spectra, 
and melting point determination (for solids). 1H, 13C, 
NMR Spectra at 500, 126, MHz, respectively. Melting 
points (°C) were recorded of solid compounds. TLC silica 
gel plates (0.25 mm) were used for monitoring the reac-
tion. Ultraviolet light (UV) was used for visualization. 
Spectrometer JMS-HX-110 equipped with a data system 
was used for recording the EI/MS spectra. For elemen-
tal analysis CHNS/O analyzer (Perkin-Elmer 2400 series) 
was used. Silica gel of various mesh sizes was used (70–
230 mesh and 30–400 mesh).
General procedure for synthesis of 3a–k and 3l–p
In a reaction vial stirring bar, catalyst Pd(PPh3)4, 
2,5-dibromo-3-methylthiophene (1 eq) was added. A dis-
posable Teflon septum was used to seal vial, which was 
first evacuated, then purged with argon thrice. 1,4-diox-
ane solvent was added with syringe with stirring under 
argon. Stirring of mixture was done at rt for 30 min. After 
that aryl boronic acid,  K3PO4 and water was added [15] 
and again vial was sealed and purged with argon three 
times and it was stirred for 12 h at 90 °C, and then cooled 
to rt. After that, ethyl acetate was used for dilution of 
mixture, the organic layer was separated and  MgSO4 was 
used for drying this layer and through the vacuum the 
remaining solvent was evaporated. The purification of 
crude product was done by the column chromatography 
by using ethyl-acetate and n-hexane (0–50% gradient) to 
obtain the desired compounds.
Characterization data
2‑Bromo‑5‑(3‑chloro‑4‑fluorophenyl)‑3‑methylthiophene 
(3a)
Obtained as a white solid, mp = 113–114  °C, (86  mg, 
56%). 1H NMR  (CD3OD, 500  MHz): δ 7.72 (dd, J = 6.5, 
2.4  Hz, 1H-aryl), 7.56–7.54 (m, 1H-aryl), 7.33–7.30 
(m, 1H-aryl, 1H-thiophene), 1.28 (s, 3H-Me); 13C NMR 
 (CD3OD, 126  MHz): δ 110.0, 109.8, 117.0, 121.3, 127.3 
(2C), 129.2, 130.5, 141.2, 142.3, 158.9, EI/MS m/z (%): 
304.9 [M+H]; 305.5 [M+2, 130.0]; 307.5 [M+4, 31.0]; 
Table 5 Antiurease activity of synthesized compounds 
(3a–k and 3l–p)
The results are average ± SD of triplicate experiments p < 0.05. Thiourea used as 
positive control
Entry Compound no Percentage inhibition at 50 µg/ml
1 3a 58.8 ± 0.58
2 3b 67.7 ± 0.77
3 3c 48.9 ± 0.65
4 3d 54.7 ± 0.67
5 3e 42.9 ± 0.45
6 3f 40.3 ± 0.40
7 3g 34.2 ± 0.38
8 3h 38.8 ± 0.45
9 3i 36.9 ± 0.45
10 3j 52.1 ± 0.78
11 3k 64.2 ± 0.87
12 Thiourea 95.6 ± 0.87
Page 8 of 12Rizwan et al. Chemistry Central Journal  (2018) 12:49 
[M-Me] = 289.0; [M-Me, Br] = 210.5. Anal. Calcd. For 
 C11H7BrClSF: C, 42.14; H, 2.42; Found: C, 42.50; H, 
2.68%.
2‑Bromo‑5‑(4‑methoxyphenyl)‑3‑methylthiophene (3b)
Obtained as a brown solid, mp = 98–99  °C, (38  mg, 
27%). 1H NMR  (CD3OD, 500 MHz): δ 7.45 (d, J = 9.0 Hz, 
2H-Aryl), 6.88 (s, 1H-thiophene), 6.92 (d, J = 9.0  Hz, 
2H-Aryl), 3.80 (s, 3H-OMe), 2.17 (s, 3H-Me); 13C NMR 
 (CD3OD, 126  MHz): δ 12.5, 56.8, 110.8, 115.8 (2C), 
126.7, 127.8, 128.5 (2C), 141.5, 143.0, 161.6, EI/MS m/z 
(%): 284.1 [M+H]; 285.2 [M+2, 90.5]; [M-Me] = 267.2, 
[M-Br] = 204.2, [M-Br, Me,  OMe]+ = 159.0. Anal. Calcd. 
For  C12H11BrOS: C, 49.9, H, 3.92; Found: C, 50.8, H, 
3.98%.
2‑Bromo‑5‑(4‑chlorophenyl)‑3‑methylthiophene (3c)
Obtained as a yellow solid, mp = 76–79  °C, (85  mg, 
60%). 1H NMR  (CD3OD, 500 MHz): δ 7.58 (d, J = 8.7 Hz, 
2H-aryl), 7.52 (d, J = 8.7 Hz, 2H-aryl), 7.13 (s, 1H- thio-
phene), 2.18 (s, 3H-Me); 13C NMR  (CD3OD, 126 MHz): 
δ 12.0, 108.4, 127.5, 128.6 (2C), 129.4 (2C), 131.6, 134.2, 
140.2, 142.2. EI/MS m/z (%): 288.2 [M+H]; 289.3 [M+2, 
130.0]; 291.0 [M+4, 31.8]; [M-Br] = 207.0; [M-Br, Cl frag-
ments] = 172.1. Anal. Calcd. For  C11H8BrClS: C, 45.9; H, 
2.80; Found: C, 45.0; H, 2.90%.
2‑Bromo‑5‑(3,5‑difluorophenyl)‑3‑methylthiophene (3d)
Obtained as a yellow solid, mp = 78–80  °C, (92  mg, 
63%). 1H NMR  (CD3OD, 500  MHz): δ 7.21–6.98 (m, 
3H-aryl), 6.25 (s, 1H-thiophene), 2.43 (s, 3H-Me); 13C 
NMR  (CD3OD, 126 MHz): δ 11.2, 103.5, 109.9 (m), 110.2, 
111.2 (2C), 127.9, 136.2, 141.2, 142.3, 165.1 (m). EI/MS 
m/z (%): 290.0 [M+H]; 291 [M+2, 90.5]; [M-2F] = 250.1, 
[M-Br] = 209.1, [M-2F, aryl fragments] = 175.0. Anal. 
Calcd. For  C11H7BrF2S: C, 44.28; H, 2.38; Found: C, 44.00; 
H, 2.42%.
1‑(3‑(5‑Bromo‑4‑methylthiophene‑2‑yl)phenyl)ethan‑1‑one 
(3e)
Obtained as a brown semisolid, (85 mg, 58%). 1H NMR 
 (CD3OD, 500  MHz): δ 8.08 (d, J = 1.5  Hz, 1H-aryl), 
7.98–7.86 (m, 1H aryl), 7.64–7.55 (m, 2H), 7.38 (s, 
1H-thiophene), 2.65 (s, 3H-OMe), 2.35 (s, 3H-Me); 13C 
NMR  (CD3OD, 126  MHz): δ 12.0, 27.0, 110.6, 126.2, 
127.0, 128.6, 129.0, 130.6, 133.7, 137.3, 141.0, 142.5, 
197.6. EI/MS m/z (%): 296.0 [M+H]; 297.5 [M+2, 95.3]; 
[M-MeCO] = 250.9, [M-Br] = 216.1. Anal. Calcd. For 
 C13H11BrOS: C, 51.79; H, 3.76; Found: C, 51.68; H, 4.00%.
2‑Bromo‑3‑methyl‑(4‑(methylthio)phenyl)thiophene (3f)
Obtained as a white solid, mp = 180–181  °C, (85  mg, 
57%). 1H NMR  (CD3OD, 500 MHz): δ 7.46 (d, J = 8.5 Hz, 
2H-Aryl), 7.25 (d, J = 10.5 Hz, 2H-Aryl), 7.09 (s, 1H-thio-
phene), 2.48 (s, 3H-SMe), 2.18 (s, 3H-Me); 13C NMR 
 (CD3OD, 126  MHz): δ 11.6, 14.8, 110.0, 127.0, 127.3 
(2C), 127.7 (2C), 130.1, 139.5, 141.5, 142.0. EI/MS m/z 
(%): 300.9 [M+H]; 301.9 [M+2, 97.5]; [M-Me] = 283.9, 
[M-SMe] = 252.6, [M-Br] = 219.0. Anal. Calcd. For 
 C12H11BrS2: C, 47.28; H, 3.82; Found: C, 47.50; H, 3.68%.
2‑Bromo‑5‑(4‑iodophenyl)‑3‑methylthiophene (3g)
Obtained as off white solid, mp = 149–150  °C, (75  mg, 
40%). 1H NMR  (CD3OD, 500 MHz): δ 7.79 (d, J = 8.7 Hz, 
2H-aryl), 7.71 (d, J = 8.7  Hz, 2H-aryl), 6.95 (s, 1H-thio-
phene), 2.19 (s, 3H-Me); 13C NMR  (CD3OD, 126 MHz): 
δ 11.5, 94.0, 110.6, 126.5, 129.0 (2C), 132.5, 138.1, 138.2, 
141.2, 144.0. EI/MS m/z (%): 380.0 [M+H]; 381.0 [M+2, 
90.7], [M-Br] = 299.0; [M-Br, Me fragments] = 283.7; 
[M-I, Br fragments] = 172.2. Anal. Calcd. For  C11H8BrIS: 
C, 33.68; H, 2.68; Found: C, 33.57; H, 2.23%.
2‑Bromo‑3‑methyl‑5‑p‑tolylthiophene (3h)
Obtained as a white solid, mp = 110–111  °C, (52  mg, 
39%). 1H NMR  (CD3OD, 500 MHz): δ 7.89 (d, J = 6.9 Hz, 
2H-aryl), 7.58 (d, J = 7.2  Hz, 2H-aryl), 6.98 (s, 1H-thio-
phene), 2.53 (s, 3H-Me), 2.15 (s, 3H-Me); 13C NMR 
 (CD3OD, 126  MHz): δ 11.4, 21.2, 109.9, 125.2 (2C), 
127.0, 129.5 (2C), 130.2, 131.9, 141.2, 142.0. EI/MS m/z 
(%): 268.0 [M+H]; 269.3 [M+2, 96.4]; [M-Br] = 187.0, 
[M-Me, Br] = 172.0; [M-Br, Me, thiophene] = 91.2. Anal. 
Calcd. For  C12H11BrS: C, 53.89; H, 3.15; Found: C, 54.4; 
H, 3.28%.
2‑Bromo‑5‑(3,5‑dimethylphenyl)‑3‑methylthiophene (3i)
Obtained as a yellow solid, mp = 120–122  °C, (58  mg, 
42%). 1H NMR  (CD3OD, 600  MHz): δ 7.21–7.15 (m, 
2H-aryl), 7.07 (s, 1H-thiophene), 6.97–6.91 (m, 1H-aryl), 
2.33 (s, 6H–2Me), 2.31 (s, 3H–Me); 13C NMR  (CD3OD, 
150  MHz): δ 11.6, 21.0 (2C), 109.5, 127.4 (3C), 130.6, 
133.0, 138.5 (2C), 141.0, 142.6. EI/MS m/z (%): 282.0 
[M+H]; 283.0 [M+2, 93.5]; [M-Me] = 264.5; [M-Me, Br 
fragments] = 186.1. Anal. Calcd. For  C13H13BrS: C, 54.5; 
H, 3.66; Found: C, 54.8; H, 4.23%.
2‑Bromo‑5‑(2,3‑dichlorophenyl)‑3‑methylthiophene (3j)
Obtained as a brown solid, mp = 103–104  °C, (72  mg, 
45%). 1H NMR  (CD3OD, 600  MHz): δ 7.61–7.58 (m, 
1H-aryl), 7.52 (dd, J = 8.0, 1.5  Hz, 1H-aryl), 7.46 (dd, 
J = 8.0, 1.5 Hz, 1H-aryl), 7.11 (s, 1H-thiophene), 2.20 (s, 
3H-Me); 13C NMR  (CD3OD, 150  MHz): δ 11.8, 110.4, 
127.1 (2C), 127.8, 130.3, 131.0, 133.6, 137.3, 141.3, 142.0. 
EI/MS m/z (%): 323.0 [M+H]; 324.3 [M+2, 164.3]; 326.0 
[M+4, 74.0]; 328.0 [M+6, 10.0]; [M-Br] = 241.0 [M-2Cl, 
Br fragments] = 171.0. Anal. Calcd. For  C11H7BrCl2S: C, 
41.0, H, 2.19; Found: C, 41.8, H, 2.42%.
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2‑Bromo‑5‑(3‑chlorophenyl)‑3‑methylthiophene (3k)
Obtained as a yellow semisolid, (46  mg, 32%). 1H NMR 
 (CD3OD, 600 MHz): δ 7.63–7.61 (m, 1H-aryl), 7.55–7.52 
(m, 2H-aryl), 7.34 (t, J = 7.8 Hz, 1H-aryl), 6.96 (s, 1H-thio-
phene), 2.19 (s, 3H-Me); 13C NMR  (CD3OD, 150 MHz): δ 
12.4, 110.4, 124.3, 127.0, 127.8, 128.9, 130.0, 134.0, 135.2, 
141.3, 142.0. EI/MS m/z (%): 288.0 [M+H]; 289.3 [M+2, 
130.0]; 291.0 [M+4, 31.5]; [M-Me] = 270.3; [M-aryl, Cl 
fragments] = 174.0. Anal. Calcd. For  C11H8BrClS: C, 45.9; 
H, 2.80; Found: C, 45.3; H, 2.23.
2,5‑Bis(3‑chloro‑4‑fluorophenyl)‑3‑methylthiophene (3l)
Obtained as a yellow solid, mp = 84–86  °C, (100  mg, 
56%). 1H NMR  (CD3OD, 500  MHz): δ 7.73 (dd, J = 6.6, 
2.4  Hz, 2H-aryl), 7.59–7.56 (m, 2H-aryl), 7.27–7.26 (m, 
2H-aryl), 7.25 (s, 1H-thiophene), 2.31 (s, 3H-Me); 13C 
NMR  (CD3OD, 126  MHz): δ 14.5, 117.0 (2C), 118.5, 
121.7 (2C), 126.0, 127.5 (m), 128.5, 129.4 (m), 130.0 (m), 
133.2, 134.2, 138.3, 158.5 (m), EI/MS m/z (%): 356.0 
[M+H]; 358.0 [M+2, 65.0]; 360.0 [M+4, 10.6]; 319.0 
[M-Me, F fragments], 300.0 [(M+4), Me, 2F fragments]. 
Anal. Calcd. For  C17H10Cl2F2S: C, 57.4, H, 2.84; Found: C, 
57.0, H, 2.82.
2,5‑Bis(4‑methoxyphenyl)‑3‑methylthiophene (3m)
Obtained as a brown solid, mp = 90–91 °C, (90 mg, 58%). 
1H NMR  (CD3OD, 500 MHz): δ 7.51 (d, J = 9.0, 4H-Aryl), 
7.38 (d, J = 9.0, 4H-Aryl), 7.07 (s, 1H-thiophene), 3.81 
(s, 6H-OMe), 2.17 (s, 3H-Me); 13C NMR  (CD3OD, 
126 MHz): δ 14.2, 55.2 (2C), 114.0 (4C), 126.0 (2C), 126.4, 
128.5 (4C), 133.0, 134.2, 138.0, 160.6 (2C), EI/MS m/z 
(%): 311.0 [M+H]; 295.2 [M-Me]; 203.4 [M-Aryl, OMe 
fragments]; Anal. Calcd. For  C19H18O2S: C, 73.5, H, 5.84; 
Found: C, 73.0, H, 5.82.
3‑Methyl‑2,5‑bis(4‑(methylthio)phenyl)thiophene (3n)
Obtained as off-white solid, mp = 160–161  °C, (75  mg, 
44%). 1H NMR  (CD3OD, 500  MHz): δ 7.41 (d, J = 8.0, 
4H-Aryl), 7.31 (d, J = 8.5, 4H-Aryl), 7.21 (s, 1H-thio-
phene), 2.51 (s, 6H-SMe), 2.31 (s, 3H-Me); 13C NMR 
 (CD3OD, 126 MHz): δ 14.8 (2C), 15.1, 126.5, 127.4 (4C), 
127.6 (4C), 130.0 (2C), 133.0, 134.6, 138.0, 139.4 (2C), EI/
MS m/z (%): 343.9 [M+H]; [M-Me]+ = 327.0, [M-Aryl, 
2-SMe]+ = 173.0. Anal. Calcd. For  C19H18S3: C, 66.6; H, 
5.30; Found: C, 66.4; H, 5.70%.
2,5‑Bis(3,5‑dimethylphenyl)‑3‑methylthiophene (3o)
Obtained as colorless oil, (45  mg, 29%). 1H NMR 
 (CD3OD, 500  MHz): δ 7.21–6.98 (m, 6H-aryl), 6.94 (s, 
1H-thiophene), 2.34 (s, 12H-Me), 2.14 (s, 3H-Me); 13C 
NMR  (CD3OD, 126 MHz): δ 14.2, 21.6 (4C), 126.2, 127.3 
(4C), 130.6 (2C), 133.0, 133.8 (2C), 134.0, 138.2, 138.9 
(4C), EI/MS m/z (%):307.0 [M+H]; [M-Me]+= 291.0; 
[M-2Me]+ = 276.0. [M-5Me]+ = 231.0. Anal. Calcd. For 
 C21H22S: C, 82.3, H, 7.24; Found: C, 82.1, H, 7.82.
2,5‑Bis(2,3‑dichlorophenyl)‑3‑methylthiophene (3p)
Obtained as brown solid, mp = 110–111  °C, (105  mg, 
53%). 1H NMR  (CD3OD, 500  MHz): δ 7.52 (dd, J = 7.8, 
1.2  Hz, 2H-aryl), 7.47–7.46 (m, 2H-aryl), 7.34–7.30 (m, 
2H-aryl), 7.10 (s, 1H-thiophene), 2.20 (s, 3H); 13C NMR 
 (CD3OD, 126  MHz): δ 15.5, 126.4, 127.2 (2C), 127.7 
(2C), 130.2 (2C), 131.4 (2C), 133.2, 133.8 (2C), 134.5, 
138.3 (3C), EI/MS m/z (%):389.0 [M+H+]; 391.0 [M+2, 
131.0]; 393.0 [M+4), 63.9]; 395.0 [M+6, 14.0]; 397.0 
[M+8), 1.2];  [M+-2Cl fragments] = 316.0;  [M+-3Cl frag-
ments] = 281.0; Anal. Calcd. For  C17H10Cl4S: C, 51.6, H, 
2.60; Found: C, 51.1, H, 2.82.
Computational methods
By using Gaussian 09 software [40] all simulations were 
performed and visualization of results was accomplished 
with Gauss view 05 [41]. All compounds geometries 
(3a–3p) were optimized by using B3LYP/6-31G(d,p) 
basis set at DFT level of theory. Frequency calculations 
at same level of theory proved true optimization (where 
no imaginary frequency was observed). Frontier molecu-
lar orbital (FMOs) analysis and molecular electrostatic 
potential (MEP) were carried out at same basis set as 
used for optimization.
Pharmacology
General procedure for antioxidant potential of synthesized 
compounds by DPPH radical scavenging activity
The DPPH radical scavenging was determined by follow-
ing the reported method [42]. In the reaction mixture 
50 µg/ml of test sample and 1 ml of DPPH (2,2-diphenyl-
1-picrylhydrazyl) solution (90  μM) was added and mix-
ture volume was made up to 3  ml. Then incubation of 
mixture was done at rt for 1  h and absorbance of solu-
tion was observed at 515 nm. Sample that contained only 
methanol was used as blank. Percentage DPPH radical 
scavenging was calculated by following formula:
where, As = absorbance of sample and Ac = absorbance of 
control (DPPH solution in methanol without sample).
General procedure for Antiurease activity
Firstly, phosphate buffer (200  µl, ~ pH = 7) having one 
unit of enzyme followed by addition of phosphate buffer 
(230 μl) and stock solution (20 μl) (thiourea or test sam-
ple). The mixture was shaked well and at 25  °C it was 
incubated for 5  min. After this, 400  µl of urea stock 
(20 mM) solution was added in every sample tube. With 
%DPPH radical scavenging activity =
(
Ac − As
Ac
)
× 100
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no urea solution the calibration mixture was prepared 
and positive control solution was prepared with no thi-
ourea solution. Then prepared sample solutions were 
incubated at 40  °C (for 10  min). After this the phenol 
hypochlorite reagent (1150 μl) was added. For formation 
of complex and colour development the tubes were fur-
ther incubated for 25 min at 56  °C. After cooling a blue 
colour complex appeared and absorbance was observed 
at 625 nm and % inhibition was calculated by the follow-
ing formula:
The  IC50 values were determined using the EZ-fit kinetic 
data base [43, 44].
General procedure for antibacterial activity
The antibacterial activity of novel molecules was carried 
out by following already reported method [45] against 
Gram positive (Staphylococcus aureus, Bacillus subtilis) 
and Gram negative (Pseudomonas aeruginosa, Escheri-
chia coli, Salmonella typhi, Shigella dysenteriae) strains. 
The bacterial strains were provided by Agha Khan Uni-
versity of Karachi, Pakistan. Streptomycin (50  µg/ml) 
was used as the positive control. Activity was determined 
by 96 well plate method. In every well sterilized broth 
(175  µl) was added and glycerol stock (5.0  µl) bacterial 
strain was inoculated. The initial absorbance reading 
maintained between 0.12 and 0.19 and in an incubator 
bacteria allowed to grow overnight. After 12 h, test sam-
ple (20  µl) was added in wells (sample conc was 20  µl/
well). The 96 well plates were further incubated (at 37 °C) 
for 24 h. After incubation the absorbance at 630 nm was 
observed by using Elisa reader. The difference in absorb-
ance was used as bacterial growth index. Percentage 
inhibition of bacterial growth was determined by the fol-
lowing formula:
Conclusion
For the synthesis of some thiophene based pharmaceu-
tically important compounds simple, mild, scalable pro-
tocols were developed. The optimized method exhibit 
enhanced substrate scope and expanded functional group 
compatibility allowing the synthesis of bundle of novel 
thiophene based structures in significant yields. Frontier 
molecular orbitals (FMOs) analysis revealed that 3n is 
most reactive having HOMO–LUMO band gap 3.89 eV, 
whereas HOMO–LUMO band gap for 3p found 4.67 eV, 
and is most stable among all. The MEP investigation 
provided us the idea about the electro and nucleophilic 
%age inhibition = 100− (O.Dof test sample/O.Dof control)
× 100
Inhibition (%) =
O.Dof positive control−O.Dof sample
O.D of positive control
× 100
nature of synthesized compounds, and it was envisaged 
that dispersion of electronic density is highly dependent 
on nature of groups attached to the aromatic ring. The 
compounds were screened for biological activities (anti-
bacterial, antiurease and antioxidant). All the tested com-
pounds showed promising biological activities. In light of 
this research it is concluded that synthesized thiophene 
derivatives might be a potential source of therapeutic 
agents. Future investigations in this dimension will pro-
vide new visions towards development of novel phar-
maceutically important drugs. And these compounds 
may also be used as intermediates in preparation of fine 
chemicals for industrial purposes.
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